| 摘要 |
A compound having the general structure shown in Formula I:
or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK, receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough. |
| 申请人 |
OPKO Health, Inc. |
发明人 |
PALANI, Anandan;HUANG, Xianhai;XIAO, Dong;PALIWAL, Sunil;TSUI, Hon-Chung;WROBLESKI, Michelle, Laci;RAO, Ashwin, U.;WANG, Cheng;SHAH, Sapna, S.;SHIH, Neng-Yang |
